Kim Jimok, Li Yong
Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Georgia Regents University, Augusta, GA, 30912, USA; Department of Neurology, Medical College of Georgia, Georgia Regents University, Augusta, GA, 30912, USA.
J Physiol. 2015 Feb 15;593(4):871-86. doi: 10.1113/jphysiol.2014.286633. Epub 2015 Jan 5.
The effects of cannabinoids are primarily mediated by two types of cannabinoid receptors, CB1 receptors in the nervous system and CB2 receptors in the immune system. Recent evidence indicates that CB2 receptors are also widely expressed in the brain and involved in neuropsychiatric functions, such as schizophrenia-like behaviours, anxiety, memory, vomiting and pain. The cellular mechanisms by which CB2 receptors regulate neuronal functions are unknown. We show that chronic activation of CB2 receptors in the hippocampus for 7-10 days increases excitatory synaptic transmission, whereas short-term activation of CB2 receptors has little effect on synaptic activity. This study reveals a novel role of CB2 receptors in the brain, which is clearly distinct from that of CB1 receptors, and thus, will help us to understand better the diverse effects of cannabinoids in the nervous system.
The roles of CB1 cannabinoid receptors in regulating neuronal activity have been extensively characterized. Although early studies show that CB1 receptors are present in the nervous system and CB2 cannabinoid receptors are in the immune system, recent evidence indicates that CB2 receptors are also expressed in the brain. Activation or blockade of CB2 receptors in vivo induces neuropsychiatric effects, but the cellular mechanisms of CB2 receptor function are unclear. The aim of this study is to determine how activation of CB2 receptors present in the hippocampus regulates synaptic function. Here, we show that when organotypic cultures of rodent hippocampal slices were treated with a CB2 receptor agonist (JWH133 or GP1a) for 7-10 days, quantal glutamate release became more frequent and spine density was increased via extracellular signal-regulated kinases. Chronic intraperitoneal injection of JWH133 into mice also increased excitatory synaptic transmission. These effects were blocked by a CB2 receptor antagonist (SR144528) or absent from hippocampal slices of CB2 receptor knock-out mice. This study reveals a novel cellular function of CB2 cannabinoid receptors in the hippocampus and provides insights into how cannabinoid receptor subtypes diversify the roles of cannabinoids in the brain.
大麻素的作用主要由两种类型的大麻素受体介导,即神经系统中的CB1受体和免疫系统中的CB2受体。最近的证据表明,CB2受体也在大脑中广泛表达,并参与神经精神功能,如精神分裂症样行为、焦虑、记忆、呕吐和疼痛。CB2受体调节神经元功能的细胞机制尚不清楚。我们发现,海马体中CB2受体的慢性激活持续7至10天会增加兴奋性突触传递,而CB2受体的短期激活对突触活动影响很小。这项研究揭示了CB2受体在大脑中的新作用,这与CB1受体明显不同,因此将有助于我们更好地理解大麻素在神经系统中的多种作用。
CB1大麻素受体在调节神经元活动中的作用已得到广泛研究。尽管早期研究表明CB1受体存在于神经系统中,CB2大麻素受体存在于免疫系统中,但最近的证据表明CB2受体也在大脑中表达。体内激活或阻断CB2受体可诱发神经精神效应,但CB2受体功能的细胞机制尚不清楚。本研究的目的是确定海马体中CB2受体的激活如何调节突触功能。在这里,我们表明,当用CB2受体激动剂(JWH133或GP1a)处理啮齿动物海马体切片的器官型培养物7至10天时,通过细胞外信号调节激酶,量子谷氨酸释放变得更加频繁,脊柱密度增加。向小鼠腹腔内长期注射JWH133也增加了兴奋性突触传递。这些效应被CB2受体拮抗剂(SR144528)阻断,或者在CB2受体基因敲除小鼠的海马体切片中不存在。这项研究揭示了CB2大麻素受体在海马体中的一种新的细胞功能,并为大麻素受体亚型如何使大麻素在大脑中的作用多样化提供了见解。